Signing of a framework agreement between Santé publique France and Inserm

Press Contacts

Santé publique France
presse@santepubliquefrance.fr
Stéphanie Champion: 01 41 79 67 48
Marie Delibéros: 01 41 79 69 61

Inserm
presse@inserm.fr

Santé publique France and Inserm (the French National Institute of Health and Medical Research) are signing an agreement today aimed at guiding, strengthening, and expanding their collaboration. Several priority areas have been identified for the next five years: emerging infectious diseases and modeling, environmental factors and health, nutrition, social inequalities, and perinatal health. This agreement will foster a stronger scientific alliance between research, surveillance, and health prevention and promotion, in support of public policy decisions.

A Strengthened Partnership Between Two Organizations with Complementary Missions

Epidemiological surveillance generates a wealth of descriptive data that contributes to our understanding of the health status of populations in real-world settings. Prevention and health promotion efforts must be based on interventions that have proven effective. These key areas of public health thus require ongoing and essential collaboration with research.

Surveillance and research are, in fact, mutually reinforcing. Surveillance, in particular, helps generate new scientific hypotheses that must be tested through research; research, in turn, can identify health issues that need to be precisely quantified and subject to dedicated surveillance. Furthermore, new knowledge derived from research informs the expert assessments and analyses produced to support public decision-making, contributes to innovations that promote health-friendly environments, and also generates hypotheses regarding emerging risks.

Given the complementary nature of their activities and the synergies to be developed, Santé publique France and Inserm have established priority areas of cooperation to strengthen exchanges and cooperation mechanisms at the intersection of research, surveillance, prevention and health promotion interventions, and expertise, in support of public health decision-making.

Shared themes and strengthened common tools

This ambition reinforces existing and, in some cases, long-standing collaborations on numerous topics, such as in the field of nutrition. Building on a longstanding partnership, the field of infectious diseases and their modeling received particular support during the SARS-CoV-2 health crisis, in collaboration with ANRS|MIE, and is now the focus of new collaborative projects. Social health inequalities are also a major issue highlighted at the heart of the health crisis and one that requires in-depth work at the intersection of research, surveillance, health promotion, and expertise.

The aim, therefore, is to strengthen scientific output across these various themes by mobilizing research to support public interventions and policies. Finally, the two institutions are also jointly committed to addressing major public health challenges, such as the impact of environmental factors—and in particular climate change—on health, mental health, and perinatal health. The goal here is to mobilize researchers—whether in basic or applied research—to support decision-making and interventions.

To advance these scientific ambitions, this agreement establishes an operational framework for collaboration among scientific staff, while ensuring the quality and independence of expertise as well as respect for the intellectual property rights of both institutions. These collaborations include, in particular, the provision of experts, the conduct of expert assessments, the generation of data, and the creation of joint teams.

The collaboration between the two organizations also covers tools and infrastructure supporting the missions and priorities of both entities:

  • cohorts, data infrastructures, and large-scale health surveys;

  • morbidity registries, and strategies for surveillance, disease description, and evaluative assessment of diagnostic and therapeutic care;

  • the National Registry of Medical Causes of Death (or CépiDc).

“To take effective and sustainable action in public health, there must be an ongoing dialogue between knowledge and action. The signing of this agreement with Inserm opens up new avenues for addressing the need to link surveillance and health prevention/promotion even more closely with research and innovation, all in the service of the health of the French people.”

Prof. Geneviève Chêne, Director General of Santé publique France

“I am delighted to sign this framework agreement, which highlights the essential contribution of research to health surveillance and prevention, as well as to public decision-making. It underscores the strong collaborations that already exist between our two institutions on infectious diseases, nutrition, and health inequalities, and opens up new avenues of collaboration, such as the impact of climate change on health. I am convinced that it is by fostering such high-level synergies that we will succeed in our mission to sustainably improve the health of our fellow citizens.”

Dr. Gilles Bloch, President of Inserm

Signing of the agreement between Geneviève Chêne (Santé publique France) and Gilles Bloch (Inserm)

Signature de la convention entre Geneviève Chêne (Santé publique France) et Gilles Bloch (Inserm)

About Santé publique France

Santé publique France addresses the need for a center of reference and expertise in public health in France. Based on the continuum between knowledge and action, our mission is to improve and protect the health of the population. Our work addresses major public health challenges over the long term, in the areas of protection against threats (including infectious risks, environmental risks, etc.) on the one hand, and health improvement (health determinants, prevention, health promotion, and reducing the burden of chronic diseases, social and regional inequalities, etc.) on the other. Santé Publique France is a public institution under the supervision of the Ministry of Solidarity and Health.

About Inserm

Founded in 1964, the French National Institute of Health and Medical Research (Inserm) is a public scientific and technological institution under the dual supervision of the Ministry of Higher Education, Research, and Innovation and the Ministry of Solidarity and Health. Inserm is the only French public organization dedicated to biological, medical, and human health research, covering the entire spectrum from the research laboratory to the patient’s bedside. Its researchers are committed to studying all diseases, from the most common to the rarest. With a budget of over €1 billion, Inserm supports nearly 350 laboratories across France. The teams as a whole comprise nearly 14,000 researchers, engineers, technicians, managers, university hospital staff, postdoctoral fellows, and others.

Our latest news

news

2026 “Sexual Behavior” Survey (ERAS) for men who have sex with men

news

Hervé Maisonneuve has been appointed scientific integrity officer for a...

Visuel illustratif

news

Public Health France 2026 Barometer: Launch of the Survey